Welcia Holdings Co., Ltd. (TYO:3141)
2,521.50
-36.00 (-1.41%)
Jul 29, 2025, 3:30 PM JST
Welcia Holdings Revenue
Welcia Holdings had revenue of 334.43B JPY in the quarter ending May 31, 2025, with 9.74% growth. This brings the company's revenue in the last twelve months to 1.31T, up 7.43% year-over-year. In the fiscal year ending February 28, 2025, Welcia Holdings had annual revenue of 1.29T with 5.56% growth.
Revenue (ttm)
1,314.70B
Revenue Growth
+7.43%
P/S Ratio
0.40
Revenue / Employee
79.15M
Employees
16,611
Market Cap
523.82B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Feb 28, 2025 | 1,285.01B | 67.67B | 5.56% |
Feb 29, 2024 | 1,217.34B | 73.06B | 6.38% |
Feb 28, 2023 | 1,144.28B | 118.33B | 11.53% |
Feb 28, 2022 | 1,025.95B | 76.30B | 8.03% |
Feb 28, 2021 | 949.65B | 81.37B | 9.37% |
Feb 29, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Feb 28, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Feb 28, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Feb 28, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Feb 29, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,196.22B |
Daiichi Sankyo Company | 1,886.26B |
Takeda Pharmaceutical Company | 4,581.55B |
HOYA Corporation | 866.03B |
Terumo | 1,036.17B |
Otsuka Holdings | 2,393.18B |
Astellas Pharma | 1,912.32B |
Shionogi & | 438.27B |